首页> 外国专利> METHOD OF OBTAINING OPTICALLY ACTIVE ALPHA-ARYLALKINIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SODIUM SALT, OR ITS C1-C4 ALKYL OR C1-C4HYDROXYALKYL ESTER

METHOD OF OBTAINING OPTICALLY ACTIVE ALPHA-ARYLALKINIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SODIUM SALT, OR ITS C1-C4 ALKYL OR C1-C4HYDROXYALKYL ESTER

机译:获得光学活性的α-芳基炔酸或其药学上可接受的钠盐或其C1-C4烷基或C1-C4羟烷基酯的方法

摘要

Pharmaceutically useful optically active alpha -arylalkanoic acids of the formula CHEM where Ar is aryl and R1 is alkyl or cycloalkyl or esters, ortho esters, or amides thereof are stereoselectively prepared by contacting a reagent of the formula Ar-MX, (Ar) 2M or ArM' where M is Cd, Cu(II), Mn(II), Mg or Zn, and M' is Cu(I) or Li, and X is halogen, with an optically active compound of the formula CHEM where Z is a leaving group and Y is halogen, acyloxy or CHEM where R' and R'' are alkyl, aryl or with N are a heterocyclic group, to form the optically active ketone of the formula CHEM which is ketalized and rearranged to said acid, ester, ortho ester or amide. Alternatively, said ketone is reduced to the corresponding alkanol, which is rearranged to the alpha -arylalkanal. The alkanal so produced is converted to said acid by conventional methods.
机译:的药学上有用的光学活性α-芳基链烷酸,其中Ar为芳基,R1为烷基或环烷基,或其酯,原酸酯或酰胺通过与式Ar-MX(Ar)的试剂接触而立体选择性地制备2M或ArM',其中M为Cd,Cu(II),Mn(II),Mg或Zn,M'为Cu(I)或Li,X为卤素,并具有式其中Z是离去基团且Y是卤素,酰氧基或,其中R'和R''是烷基,芳基或其中N是杂环基,以形成缩酮化的式的光学活性酮并重排为所述酸,酯,原酸酯或酰胺。或者,所述酮被还原为相应的链烷醇,其被重排为α-芳基链烷醛。通过常规方法将如此产生的链烷醛转化为所述酸。

著录项

  • 公开/公告号SU1577694A3

    专利类型

  • 公开/公告日1990-07-07

    原文格式PDF

  • 申请/专利权人 SINTEKS FARMASYOTIKALS INTERNESHNL LTD (VM);

    申请/专利号SU19823524059

  • 发明设计人 DZHORDZH K.SHLEMER;

    申请日1982-12-10

  • 分类号C07C57/40;C07C69/616;

  • 国家 SU

  • 入库时间 2022-08-22 06:11:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号